Reduction of serum lipid levels, and agents and compositions useful therefor
AssigneeSyntex (U.S.A.) Inc.
InventorWendell H. Rooks, II
Life of this patent
Estimating the term…
Loading patent…
AssigneeSyntex (U.S.A.) Inc.
InventorWendell H. Rooks, II
Estimating the term…
A method for lowering elevated serum lipid concentrations comprising administering a composition containing, as the active ingredient, a 3.beta. -substituted-16.alpha.-cyanopreg-5-en-20-one wherein the substituent at the 3.beta.-position is selected from the group consisting of hydroxy, alkoxy having 1 to 6 carbon atoms, cycloalkoxy having 3 to 6 carbon atoms, acyloxy wherein the acyl moiety has 2 to 7 carbon atoms, tetrahydrofuran-2'-yloxy, tetrahydropyran-2'-yloxy, and 4'-alkoxytetrahydropyran-4'-yloxy where the alkoxy moiety has 1 to 6 carbon atoms. Representative active ingredients are 3.beta.-acetoxy-16.alpha.-cyanopreg-5-en-20-one and 3.beta.-cyclopentyloxy-16.alpha.-cyanopregn-5-en-20-one. These representative agents are also useful in the therapeutic method of protecting and regenerating damaged hepatic tissue.
A compound selected from the group of compounds represented by the formula:
Dependencies are inferred from the claim text.